Amniotic membrane transplantation with fibrin glue for conjunctivochalasis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17659969.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the feasibility of performing sutureless amniotic membrane transplantation (AMT) using fibrin glue for conjunctivochalasis. Noncomparative interventional case series. In 25 eyes of 16 patients with refractory conjunctivochalasis (CCh), AMT using fibrin glue was performed to cover the bare sclera. The mean age was 55.2 +/- 18.5 years with nine patients (56.2%) younger than 60 years. The Tenon capsule was dissolved in all eyes. Fibrin glue was effective in securing the amniotic membrane to the sclera. For a mean follow-up of 10.6 +/- 4.3 months, all eyes achieved a smooth conjunctival surface with complete or significant improvement of symptoms in 44% and 56%, respectively. Complications included focal conjunctival inflammation in four eyes and pyogenic granuloma in one eye. AMT using fibrin glue can be performed for refractory CCh resulting in alleviating its symptoms and signs.
Medical subject headings
- Amnion
- Biological Dressings
- Conjunctival Diseases
- Fetal Tissue Transplantation
- Fibrin Tissue Adhesive
- Suture Techniques
- Tissue Adhesives